3.0
Summary
| Name |  cinolazepam
|
| Synonyms | 1-(2-cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (ChEBI), 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile (ChEBI), 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile (ChemIDplus), cinolazepam (KEGG DRUG), cinolazepamum (ChemIDplus) |
| IUPAC | 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]propanenitrile |
| Formula | C18H13ClFN3O2 |
| PRIMARY ID (Read more) |
CHEBI:59514 |
| Type | chemical |
| Relations | 1 |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Relations
| Regulator | Mechanism | target | score ℹ | |
|---|---|---|---|---|
| + | cinolazepam | up-regulates activity 
chemical activation
|
GABA-A (a1-b1-g2) receptor | 0.8 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Tissue: | Central Nervous System | |||